These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 32854726)

  • 1. A novel neoantigen discovery approach based on chromatin high order conformation.
    Shi Y; Zhang M; Meng L; Su X; Shang X; Guo Z; Li Q; Lin M; Zou X; Luo Q; Yu Y; Wu Y; Da L; Cai TW; He G; Han ZG
    BMC Med Genomics; 2020 Aug; 13(Suppl 6):62. PubMed ID: 32854726
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3D genome contributes to MHC-II neoantigen prediction.
    Feng M; Liu L; Su K; Su X; Meng L; Guo Z; Cao D; Wang J; He G; Shi Y
    BMC Genomics; 2024 Sep; 25(Suppl 2):889. PubMed ID: 39327585
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DeepAntigen: a novel method for neoantigen prioritization via 3D genome and deep sparse learning.
    Shi Y; Guo Z; Su X; Meng L; Zhang M; Sun J; Wu C; Zheng M; Shang X; Zou X; Cheng W; Yu Y; Cai Y; Zhang C; Cai W; Da LT; He G; Han ZG
    Bioinformatics; 2020 Dec; 36(19):4894-4901. PubMed ID: 32592462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TruNeo: an integrated pipeline improves personalized true tumor neoantigen identification.
    Tang Y; Wang Y; Wang J; Li M; Peng L; Wei G; Zhang Y; Li J; Gao Z
    BMC Bioinformatics; 2020 Nov; 21(1):532. PubMed ID: 33208106
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prediction and prioritization of neoantigens: integration of RNA sequencing data with whole-exome sequencing.
    Karasaki T; Nagayama K; Kuwano H; Nitadori JI; Sato M; Anraku M; Hosoi A; Matsushita H; Takazawa M; Ohara O; Nakajima J; Kakimi K
    Cancer Sci; 2017 Feb; 108(2):170-177. PubMed ID: 27960040
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comprehensive profiling of cancer neoantigens from aberrant RNA splicing.
    Wickland DP; McNinch C; Jessen E; Necela B; Shreeder B; Lin Y; Knutson KL; Asmann YW
    J Immunother Cancer; 2024 May; 12(5):. PubMed ID: 38754917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neodb: a comprehensive neoantigen database and discovery platform for cancer immunotherapy.
    Wu T; Chen J; Diao K; Wang G; Wang J; Yao H; Liu XS
    Database (Oxford); 2023 Jun; 2023():. PubMed ID: 37311149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A proteogenomic approach to target neoantigens in solid tumors.
    Verma A; Halder A; Marathe S; Purwar R; Srivastava S
    Expert Rev Proteomics; 2020; 17(11-12):797-812. PubMed ID: 33491499
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immune-based mutation classification enables neoantigen prioritization and immune feature discovery in cancer immunotherapy.
    Bai P; Li Y; Zhou Q; Xia J; Wei PC; Deng H; Wu M; Chan SK; Kappler JW; Zhou Y; Tran E; Marrack P; Yin L
    Oncoimmunology; 2021 Jan; 10(1):1868130. PubMed ID: 33537173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Utilizing immunogenomic approaches to prioritize targetable neoantigens for personalized cancer immunotherapy.
    Shah RK; Cygan E; Kozlik T; Colina A; Zamora AE
    Front Immunol; 2023; 14():1301100. PubMed ID: 38149253
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neopepsee: accurate genome-level prediction of neoantigens by harnessing sequence and amino acid immunogenicity information.
    Kim S; Kim HS; Kim E; Lee MG; Shin EC; Paik S; Kim S
    Ann Oncol; 2018 Apr; 29(4):1030-1036. PubMed ID: 29360924
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neoantigen identification strategies enable personalized immunotherapy in refractory solid tumors.
    Chen F; Zou Z; Du J; Su S; Shao J; Meng F; Yang J; Xu Q; Ding N; Yang Y; Liu Q; Wang Q; Sun Z; Zhou S; Du S; Wei J; Liu B
    J Clin Invest; 2019 May; 129(5):2056-2070. PubMed ID: 30835255
    [TBL] [Abstract][Full Text] [Related]  

  • 13. GNIFdb: a neoantigen intrinsic feature database for glioma.
    Li W; Sun T; Li M; He Y; Li L; Wang L; Wang H; Li J; Wen H; Liu Y; Chen Y; Fan Y; Xin B; Zhang J
    Database (Oxford); 2022 Feb; 2022():. PubMed ID: 35150127
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of shared neoantigens in esophageal carcinoma by the combination of comprehensive analysis of genomic data and in silico neoantigen prediction.
    Yuan Y; Chen C; Liu S; Xiong H; Huang Y; Zhang X; Zhang X; Li B
    Cell Immunol; 2022 Jul; 377():104537. PubMed ID: 35636066
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of an aggressive orthotopic murine glioblastoma model with combination checkpoint blockade and a multivalent neoantigen vaccine.
    Liu CJ; Schaettler M; Blaha DT; Bowman-Kirigin JA; Kobayashi DK; Livingstone AJ; Bender D; Miller CA; Kranz DM; Johanns TM; Dunn GP
    Neuro Oncol; 2020 Sep; 22(9):1276-1288. PubMed ID: 32133512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cancer Neoantigens: Challenges and Future Directions for Prediction, Prioritization, and Validation.
    Borden ES; Buetow KH; Wilson MA; Hastings KT
    Front Oncol; 2022; 12():836821. PubMed ID: 35311072
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement in neoantigen prediction via integration of RNA sequencing data for variant calling.
    Nguyen BQT; Tran TPD; Nguyen HT; Nguyen TN; Pham TMQ; Nguyen HTP; Tran DH; Nguyen V; Tran TS; Pham TN; Le MT; Phan MD; Giang H; Nguyen HN; Tran LS
    Front Immunol; 2023; 14():1251603. PubMed ID: 37731488
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Identification of neoantigens and development of antigen-specific immunotherapy].
    Shinohara S; Takahashi Y; Demachi-Okamura A; Matsushita H
    Rinsho Ketsueki; 2020; 61(9):1433-1439. PubMed ID: 33162546
    [TBL] [Abstract][Full Text] [Related]  

  • 19. pVACview: an interactive visualization tool for efficient neoantigen prioritization and selection.
    Xia H; Hoang M; Schmidt E; Kiwala S; McMichael J; Skidmore ZL; Fisk B; Song JJ; Hundal J; Mooney T; Walker JR; Peter Goedegebuure S; Miller CA; Gillanders WE; Griffith OL; Griffith M
    ArXiv; 2024 Jun; ():. PubMed ID: 38947921
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [A method of screening highly common neoantigens with immunogenicity in colorectal cancer based on public somatic mutation library].
    Qin LL; Li YJ; Liang ZR; Dai L; Li WH; Chen C; Huang YL; Zhang L; Liu SM; Qiu S; Ge YP; Peng WT; Lin XX; Zhang XQ; Dong X; Li B
    Yi Chuan; 2020 Jun; 42(6):599-612. PubMed ID: 32694118
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.